Corpus Intelligence IC Memo — UVA ENCOMPASS HEALTH REHABILITATION 2026-04-26 12:04 UTC
IC Memo — UVA ENCOMPASS HEALTH REHABILITATION
Investment Committee Memorandum | VA | 50 beds | Grade C | EBITDA uplift $1.8M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UVA ENCOMPASS HEALTH REHABILITATION

CCN 493029 | ALBEMARLE, VA | 50 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

UVA ENCOMPASS HEALTH REHABILITATION is a 50-bed suburban community hospital in ALBEMARLE, VA with $24.2M in net patient revenue and a 10.6% operating margin. The hospital serves a payer mix of 55.7% Medicare, 0.1% Medicaid, and 44.2% commercial.

Thesis: Turnaround. Our ML models identify $1.8M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 10.6% to 18.0% (+736bps).

Net Revenue HCRIS$24.2M
Current EBITDA COMPUTED$2.6M
Operating Margin COMPUTED10.6%
Occupancy HCRIS82.8%
Revenue / Bed COMPUTED$483K
Net-to-Gross HCRIS67.3%
Distress Probability ML45.8%

2. Market Context & Competitive Position

111
VA Hospitals
4.4%
State Median Margin
50
Comparable Hospitals

VA has 111 Medicare-certified hospitals with a median operating margin of 4.4%. The target's margin of 10.6% places it above the state median. Among 50 size-comparable peers (25-100 beds), the median margin is 4.8%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (25-100), prioritizing same-state peers. 50 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UVA ENCOMPASS HEALTH REHABILIT (Target)VA50$24.2M10.6%
CARILION NEW RIVER VALLEY MED VA94$261.3M-0.5%
RICHMOND COMMUNITY HOSPITALVA96$254.9M21.5%
JOHNSTON MEMORIAL HOSPITALVA100$188.3M6.1%
LONESOME PINE HOSPITALVA56$175.6M17.2%
LEWISGALE HOSPITAL - MONTGOMERVA92$155.7M40.7%
CULPEPER MEMORIAL HOSPITALVA70$153.9M9.3%
COMMUNITY MEMORIAL HOSPITALVA66$135.2M-31.0%
STAFFORD HOSPITALVA61$127.9M5.7%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.8M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$507K+210bp18mo
Cost to Collect4.5%2.5%$483K+200bp12mo
Denial Rate Reduction12.0%6.5%$478K+198bp12mo
A/R Days Reduction5200.0%3800.0%$294K+122bp9mo
Clean Claim Rate88.0%96.0%$15K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$507K
Cost to Collect
$483K
Denial Rate Reduction
$478K
A/R Days Reduction
$294K
Clean Claim Rate
$15K
Total EBITDA Uplift$1.8M
Current EBITDA$2.6M
+ RCM Uplift+$1.8M
Pro Forma EBITDA$4.3M
Current Margin10.6%
Pro Forma Margin18.0%
WC Released (1x)$926K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.9M$34.7M8.79x54.4%
Base (11x exit)10.0x11.0x$3.9M$39.5M9.99x58.5%
Bull Case9.0x11.0x$3.6M$46.6M13.11x67.3%
Bull (12x exit)9.0x12.0x$3.6M$51.9M14.60x71.0%
Bear Case11.0x10.0x$4.3M$24.5M5.65x41.4%
Bear (11x exit)11.0x11.0x$4.3M$28.4M6.54x45.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 55.7% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 50 hospitals with 25-100 beds
  • Same-state prioritization (n=51)
  • Comp margins: P25=-9.8% / P50=4.8% / P75=14.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.